Alfa Wassermann Diagnostic Technologies, LLC - Product Pipeline Analysis - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Alfa Wassermann Diagnostic Technologies, LLC - Product Pipeline Analysis

Description:

Alfa Wassermann Diagnostic Technologies, LLC (AWDT) is the provider of medical diagnostic instrumentation and reagents to the medical community. It offers diagnostics equipment to the physician office and veterinary lab markets. The product portfolio of the company comprises ACE Axcel Clinical Chemistry System, ACE Alera Chemistry System, Alfa Laboratory Information System (LIS), Vet Alera Chemistry Analyzer and Vet LIS. It operates as the subsidiary of Alfa Wassermann, Inc. AWDT is headquartered in New Jersey, the US. – PowerPoint PPT presentation

Number of Views:171
Slides: 8
Provided by: aarkresearch
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Alfa Wassermann Diagnostic Technologies, LLC - Product Pipeline Analysis


1
Lab21 Limited - Product Pipeline AnalysisMarket
Research Reports Distributor - Aarkstore.com have
vast database on market research reports, company
financials, company profiles, SWOT analysis,
company report, company statistics, strategy
review, industry report, industry research to
provide excellent and innovative service to our
report buyers.Aarkstore.com have very
interactive search feature to browse across more
than 2,50,000 business industry reports. We are
built on the premise that reading is valuable,
capable of stirring emotions and firing the
imagination. Whether you're looking for new
market research report product trends or
competitive industry analysis of a new or
existing market, Aarkstore.com has the best
resource offerings and the expertise to make sure
you get the right product every time.
2
Lab21 Limited - Product Pipeline Analysis
  • SummaryLab21 Limited (Lab21) is a personalized
    healthcare company. The company offers diagnostic
    products and services and supports medical
    diagnostics, blood bank screening and drug
    discovery. Lab21serves pharmaceutical and
    diagnostic firms and international healthcare
    providers. Lab21s diagnostic product division
    manufactures immuno-diagnostic kits and reagents
    which is focused on infectious diseases for the
    blood banking and clinical markets. Its clinical
    services operations provides high technology
    molecular assays and companion diagnostics. Lab21
    has office in South Carolina, the US and
    Cambridge, the UK with a GMP manufacturing
    facility in Cambridge and other manufacturing
    sites in Camberley, Bridport and Newmarket. The
    company is headquartered in Cambridge, the
    UK.The company plans to develop fully automated
    polymerase chain reaction based assays on the BD
    MAX platform as recently it entered into a
    collaboration with Becton, Dickinson and
    Company.This report is a source for data,
    analysis and actionable intelligence on the Lab21
    Limited portfolio of pipeline products. The
    report provides detailed analysis on each
    pipeline product with information on the
    indication, the development stage, trial phase,
    product milestones, pipeline territory, estimated
    approval date, and estimated launch dateEach
    pipeline product is profiled to cover information
    on product description, function, technology,
    indication, and application. The report is also
    supplemented with a detailed company profile and
    information on clinical trials, wherever
    applicable.This report is built using data and
    information sourced from proprietary databases,
    primary and secondary research and in-house
    analysis by GlobalDatas team of industry
    experts.

3
  • Scope- Detailed company profile with
    information on business description, key company
    facts, major products and services, key
    competitors, key employees, locations and
    subsidiaries and recent developments.- Detailed
    coverage on all the pipeline products, by
    equipment type, by therapy area, by development
    stage, and by trial phase.- Information on
    product milestones and pipeline territory for
    each product, the estimated approval date, and
    estimated launch date.- Profile of each pipeline
    product with additional information on product
    description, function, technology, indication(s),
    and application.- Data on relevant clinical
    trials and product patent details, wherever
    applicable.- Information on clinical trial,
    wherever applicable, is supplemented with
    information on trial phase, trial status, trial
    objective, trial design, target patients, unique
    physician identifier, primary point, secondary
    point, acronym, participants inclusion,
    participants exclusion, interventions, trial
    results, trial start date, trial end date, study
    type, trial site, trial funding, age eligibility,
    and gender eligibility.
  • Reasons to Buy- Develop business strategies by
    understanding the trends and developments driving
    the medical devices pipeline and technology
    landscape globally.- Design and develop your
    product development, marketing and sales
    strategies.- Exploit MA opportunities by
    identifying market players with the most
    innovative pipeline.- Develop market-entry and
    market expansion strategies.- Exploit
    in-licensing and out-licensing opportunities by
    identifying products, most likely to ensure a
    robust return.- Identify emerging players with
    potentially strong product portfolio and create
    effective counter-strategies to gain competitive
    advantage.- Develop competition strategies by
    identifying the status and likely launch of your
    competitors pipeline products through review of
    the clinical trials, stage and phase of
    development, etc.- Which are the next high-value
    products that your competitor would add in its
    portfolio? identify, understand and capitalize.

4
  • List of Tables 3List of Figures 3Key Facts
    4Lab21 Limited - Major Products and Services
    5Lab21 Limited Pipeline Products by Equipment
    Type 6Lab21 Limited Pipeline Products by
    Development Stage 8Lab21 Limited Pipeline
    Products by Therapy Area 10Lab21 Limited
    Pipeline Products by Milestone Summary
    12Companion Diagnostic Test - Infectious Disease
    14Companion Diagnostic Test - Infectious Disease
    Product Status 14Companion Diagnostic Test -
    Infectious Disease Product Description
    14MycAssay Aspergillus Test 15MycAssay
    Aspergillus Test Product Status 15MycAssay
    Aspergillus Test Product Description 15MycAssay
    Aspergillus Test Product Milestone 15MycAssay
    Pneumocystis Test 17MycAssay Pneumocystis Test
    Product Status 17MycAssay Pneumocystis Test
    Product Description 17MycAssay Pneumocystis Test
    Product Milestone 17Onconostica 19Onconostica
    Product Status 19Onconostica Product Description
    19Lab21 Limited - Key Competitors 20Lab21
    Limited - Key Employees 21Lab21 Limited -
    Locations And Subsidiaries 22Head Office
    22Other Locations Subsidiaries 22Recent
    Developments 23Lab21 Limited, Recent
    Developments 23Jun 26, 2012 Lab21 partners
    pharmaceutical Company To Develop New Companion
    Diagnostic Assay 23May 15, 2012 Lab21 Secures
    European And US Patents For HCV Drug Resistance
    Genotyping 23May 11, 2012 Lab21 Unveils New
    Molecular Analysis Services At Greenville Site
    24Mar 06, 2012 Lab21 And ITOR Launch Clinical
    Genomics Center In US 24Feb 20, 2012 Lab21
    Appoints Fraser Logue As Director Of Quality,
    Regulatory Affairs And Operations Excellence
    24Feb 16, 2012 Lab21 Launches New Lung Cancer
    Companion Diagnostic Service 25Appendix
    26Methodology 26About GlobalData 26Contact Us
    26Disclaimer 26

5
  • List of Tables Lab21 Limited, Key Facts 1Lab21
    Limited Key Pipeline Products by Equipment Type
    1Lab21 Limited Key Pipeline Products by Therapy
    Area 1Lab21 Limited Key Pipeline Products by
    Development Stage 1Lab21 Limited, Key Facts
    4Lab21 Limited, Major Products and Services
    5Lab21 Limited Number of Pipeline Products by
    Equipment Type 6Lab21 Limited Pipeline Products
    by Equipment Type 7Lab21 Limited Number of
    Pipeline Products by Development Stage 8Lab21
    Limited Pipeline Products by Development Stage
    9Lab21 Limited Number of Pipeline Products by
    Therapy Area 10Lab21 Limited Pipeline Products
    by Therapy Area 11Lab21 Limited Number of
    Pipeline Products By Milestone Summary 12Lab21
    Limited Pipeline Products by Milestone Summary
    13Companion Diagnostic Test - Infectious Disease
    - Product Status 14Companion Diagnostic Test -
    Infectious Disease - Product Description
    14MycAssay Aspergillus Test - Product Status
    15MycAssay Aspergillus Test - Product
    Description 15MycAssay Aspergillus Test -
    Product Milestone 15MycAssay Pneumocystis Test -
    Product Status 17MycAssay Pneumocystis Test -
    Product Description 17MycAssay Pneumocystis Test
    - Product Milestone 17Onconostica - Product
    Status 19Onconostica - Product Description
    19Lab21 Limited, Key Employees 21Lab21 Limited,
    Subsidiaries 22
  • List of Figures Lab21 Limited Key Pipeline
    Products by Equipment Type 1Lab21 Limited
    Pipeline Products by Equipment Type 6Lab21
    Limited Pipeline Products by Development Stage
    8Lab21 Limited Pipeline Products by Therapy Area
    10Lab21 Limited Pipeline Products by Milestone
    Summary 12 

6
  • For more information, please visit
  • http//www.aarkstore.com/reports/Lab21-Limited-Pro
    duct-Pipeline-Analysis-240115.html
  • Or email us at contact_at_aarkstore.com or call
    919272852585
  • Related Reports
  • 2013 French Hospital Hematology and Flow
    Cytometry Market
  • United Arab Emirates In Vitro Diagnostics
    Investment Opportunities, Analysis and Forecasts
    to 2018
  • Chile In Vitro Diagnostics Investment
    Opportunities, Analysis and Forecasts to 2018
  • Norway In Vitro Diagnostics Investment
    Opportunities, Analysis and Forecasts to 2018
  • Aleva Neurotherapeutics SA - Product Pipeline
    Analysis.
  • DiaPat GmbH - Product Pipeline Analysis.
  • Manhattan Scientifics, Inc. (MHTX) - Product
    Pipeline Analysis.
  • MicroTransponder Inc. - Product Pipeline
    Analysis.
  • Neurostream Technologies G.P. - Product Pipeline
    Analysis.
  • Pop Test LLC - Product Pipeline Analysis.

7
  • Contact Us
  • Aarkstore Enterprise
  • Tel 912227453309
  • Mobile No08149852585
  • Email contact_at_aarkstore.com
  • Website http//www.aarkstore.com
  • Blog http//www.emarketreports.com
  • http//teju-aarkstoreenterprise.blogspot.in
  • Follow us on twitter http//twitter.com/aarkstore
    dotcom
  • http//in.linkedin.com/in/aarkstore
  • http//www.facebook.com/aarkstoreenterprise
About PowerShow.com